Prebiotics Progress Shifts in the Intestinal Microbiome That Benefits Patients with Type 2 Diabetes Mellitus

Prebiotics Progress Shifts in the Intestinal Microbiome That Benefits Patients with Type 2 Diabetes Mellitus

Hypoglycemic medications that could be co-administered with prebiotics and functional foods can potentially reduce the burden of metabolic diseases such as Type 2 Diabetes Mellitus (T2DM). The efficacy of drugs such as metformin and sulfonylureas can be enhanced by the activity of the intestinal mic...

Full description

Bibliographic Details
Main Authors: Luis Vitetta, Nick N. Gorgani, Gemma Vitetta, Jeremy D. Henson
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Biomolecules
Subjects:
prebiotics
intestinal microbiome
short chain fatty acids
butyrate
functional foods
Type 2 Diabetes Mellitus
Online Access:https://www.mdpi.com/2218-273X/13/9/1307

Internet

https://www.mdpi.com/2218-273X/13/9/1307

Similar Items